Pilot Study of the Effects of the Angiotensin-Converting Enzyme Inhibitor CI-906 on Patients with Essential Hypertension (Q62090294)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6090509%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

title

Pilot study of the effects of the angiotensin-converting enzyme inhibitor CI-906 on patients with essential hypertension (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6090509%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

Pilot Study of the Effects of the Angiotensin-Converting Enzyme Inhibitor CI-906 on Patients with Essential Hypertension (English)

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1984.TB02786.X

2 August 2023

author name string

I. Gavras

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6090509

2 August 2023

D. Vlahakos

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6090509

2 August 2023

J. C. Melby

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6090509

2 August 2023

H. Gavras

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6090509

2 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6090509

2 August 2023

publication date

1 August 1984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6090509%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

26 October 2019

http://www.jclinpharm.org/cgi/content/abstract/24/8-9/343

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6090509

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fj.1552-4604.1984.tb02786.x

2 August 2023

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1984.TB02786.X

http://onlinelibrary.wiley.com/wol1/doi/10.1002/j.1552-4604.1984.tb02786.x/fullpdf

2 August 2023

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1984.TB02786.X

The Journal of Clinical Pharmacology

2 August 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6090509%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6090509%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

issue

8-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6090509%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

page(s)

343-350

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6090509%20AND%20SRC:MED&resulttype=core&format=json

Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in Man

26 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1984.TB02786.X

Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients

2 August 2023

2

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1984.TB02786.X

Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive Patients

2 August 2023

3

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1984.TB02786.X

Medical intelligence drug therapy: captopril

2 August 2023

4

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1984.TB02786.X

Improvement of chronic congestive heart-failure by oral captopril

2 August 2023

5

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1984.TB02786.X

Sustained Effectiveness of Converting-Enzyme Inhibition in Patients with Severe Congestive Heart Failure

2 August 2023

6

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1984.TB02786.X

Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy

2 August 2023

7

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1984.TB02786.X

A placebo-controlled trial of captopril in refractory chronic congestive heart failure. Captopril Multicenter Research Group

2 August 2023

8

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1984.TB02786.X

Safety and efficacy of chronic therapy with captopril in hypertensive patients: an update

2 August 2023

9

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1984.TB02786.X

A new class of angiotensin-converting enzyme inhibitors

2 August 2023

10

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1984.TB02786.X

ANTIHYPERTENSIVE EFFECT OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME INHIBITOR "MK-421"

2 August 2023

11

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1984.TB02786.X

A comparative pilot study of enalapril, a new converting enzyme inhibitor, and hydrochlorothiazide in essential hypertension

2 August 2023

12

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1984.TB02786.X

Antihypertensive and metabolic effects of a new converting enzyme inhibitor, enalapril

2 August 2023

13

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1984.TB02786.X

The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril

2 August 2023

14

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1984.TB02786.X

Evaluation of a long-acting converting enzyme inhibitor (enalapril) for the treatment of chronic congestive heart failure

2 August 2023

15

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1984.TB02786.X

2 August 2023

Captopril and Enalapril

16

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1984.TB02786.X

The renin system: Variations in man measured by radioimmunoassay or bioassay

2 August 2023

19

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1984.TB02786.X

Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril

2 August 2023

21

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1984.TB02786.X

Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension

2 August 2023

22

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1984.TB02786.X

Differences in response to the peptidyldipeptide hydrolase inhibitors SQ 20,881 and SQ 14,225 in normal-renin essential hypertension

2 August 2023

23

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1984.TB02786.X

The opposing effects of chronic angiotensin-converting enzyme blockade by captopril on the responses to exogenous angiotensin II and vasopressin vs. norepinephrine in rats

2 August 2023

24

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1984.TB02786.X

Central and peripheral indices of sympathetic activity after blood pressure lowering with enalapril (MK-421) or hydralazine in normotensive rats

2 August 2023

25

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1984.TB02786.X

2 August 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6090509%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference